Except for anti-osteoporosis drugs, it has been reported that the systemic administration of FGF-1 (fibroblast growth factor-1) and BMP-7 (bone morphogenetic protein-7) promote the healing of osteoporotic fractures [9]. The gene discussed is FGF1; the disease is osteoporosis.